Schedule 13G ownership disclosure
Rapport Therapeutics Inc
Common Stock, $0.001 par value per share · CUSIP: 75383L102
Event date: 2025-09-30
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Cormorant Asset Management, LP
Shares: 3,192,521.00 · Class: 6.70%
- Bihua Chen
Shares: 3,192,521.00 · Class: 6.70%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001172661-25-004952
- Form type
- SCHEDULE 13G/A
- Filer
- Cormorant Asset Management, LP
- CIK
- CIK 1583977
- Filed
- Nov 14, 2025
- Reporting period
- Sep 30, 2025
- Description
- Schedule 13G beneficial ownership